The Effect of Body Mass Index on Short-term Results of HTO
Launched by EGYMEDICALPEDIA · Sep 6, 2024
Trial Information
Current as of November 08, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how body weight, measured by Body Mass Index (BMI), affects the short-term results of a specific knee surgery called High Tibial Osteotomy (HTO). This surgery is often recommended for people who have knee osteoarthritis, which is a type of arthritis that causes pain and stiffness in the knee joint. The goal of the study is to understand if a person's weight influences how well they recover from this surgery.
To participate in this trial, you need to have osteoarthritis in only one knee and have not found relief from other treatments. You should be generally healthy, not have serious medical conditions, and be willing to undergo surgery. Additionally, your knee should have certain characteristics, like a specific range of motion and alignment issues. However, individuals with severe obesity or those whose osteoarthritis is caused by other serious health problems may not be eligible. If you join the study, you can expect to receive care related to the surgery and be part of a team that is researching how weight impacts recovery, which could help improve outcomes for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Meet the diagnostic criteria for knee osteoarthritis and only have one knee
- • No serious underlying medical disease
- • Conservative treatment is ineffective and there is a willingness for surgery
- • X-ray shows degeneration limited to the medial joint space (Ahlback grade ≥ grade II)
- • Knee flexion range of motion \> 90°, varus deformity \< 15°, flexion contracture \< 5°.
- • Clinical examination shows intact anterior cruciate ligament and collateral ligament, tenderness point is limited to the medial joint space, and the lateral compartment and patellofemoral joint are intact.
- Exclusion Criteria:
- • knee osteoarthritis caused by infection, blood-related or autoimmune diseases.
- • severe obesity (BMI\>35 kg/m 2 ) or morbid obesity (obesity caused by diseases such as hypercortisolism and hypothyroidism, BMI≥30 kg/m 2 ).
About Egymedicalpedia
eGymedicalpedia is a leading clinical trial sponsor dedicated to advancing medical research and innovation. With a focus on enhancing patient outcomes, eGymedicalpedia specializes in the design, implementation, and management of clinical trials across various therapeutic areas. The organization leverages cutting-edge technology and a robust network of healthcare professionals to ensure compliance with regulatory standards while prioritizing patient safety. Committed to transparency and collaboration, eGymedicalpedia aims to accelerate the development of groundbreaking treatments and therapies that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, Egypt
Patients applied
Trial Officials
Maysara Abdelhaleem Bayuomy, Assist.Prof
Study Chair
Orthopedic &Trauma surgery Department, Faculty of medicine, Al-Azhar University, Assiut
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported